Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial results for ONC1-0013B in progressive metastatic castration-resistant prostate cancer report safety, tolerability, and pharmacokinetics; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ONC1-0013B

Snippet

Sponsor: Avionco LLC | Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 1 | Status: COMPLETED